01477.HK
Ocumension Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 5.37
+1.23%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -1.13x
- Net debt / EBITDA
- -0.08x
Liquidity & coverage
- Current ratio
- 3.31x
- Quick ratio
- 3.09x
- Cash ratio
- 0.96x
- Interest coverage
- -91.31x
- EBITDA / interest
- -58.03x
- Working capital
- HKD 751.2M
Cash & dividend
- FCF / debt
- -1.24x
- Cash flow / debt
- -0.36x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026